Follow
Tibor Casian
Title
Cited by
Cited by
Year
The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations–printability–process modulation, with …
K Ilyés, NK Kovács, A Balogh, E Borbás, B Farkas, T Casian, G Marosi, ...
European Journal of Pharmaceutical Sciences 129, 110-123, 2019
1362019
Development, validation and comparison of near infrared and Raman spectroscopic methods for fast characterization of tablets with amlodipine and valsartan
T Casian, A Reznek, AL Vonica-Gligor, J Van Renterghem, T De Beer, ...
Talanta 167, 333-343, 2017
472017
3D floating tablets: Appropriate 3D design from the perspective of different in vitro dissolution testing methodologies
K Ilyés, A Balogh, T Casian, T Igricz, E Borbás, B Démuth, P Vass, ...
International journal of pharmaceutics 567, 118433, 2019
402019
Electrospun amorphous solid dispersions of meloxicam: Influence of polymer type and downstream processing to orodispersible dosage forms
T Casian, E Borbás, K Ilyés, B Démuth, A Farkas, Z Rapi, C Bogdan, ...
International journal of pharmaceutics 569, 118593, 2019
392019
QbD for pediatric oral lyophilisates development: risk assessment followed by screening and optimization
T Casian, S Iurian, C Bogdan, L Rus, M Moldovan, I Tomuta
Drug Development and Industrial Pharmacy 43 (12), 1932-1944, 2017
392017
Fluidised bed granulation of two APIs: QbD approach and development of a NIR in-line monitoring method
A Gavan, S Iurian, T Casian, A Porfire, S Porav, I Voina, A Oprea, I Tomuta
Asian Journal of Pharmaceutical Sciences 15 (4), 506-517, 2020
332020
Challenges and opportunities of implementing data fusion in process analytical technology—a review
T Casian, B Nagy, B Kovács, DL Galata, E Hirsch, A Farkas
Molecules 27 (15), 4846, 2022
292022
QbD guided development of immediate release FDM-3D printed tablets with customizable API doses
AG Crișan, S Iurian, A Porfire, LM Rus, C Bogdan, T Casian, RC Lucacel, ...
International journal of pharmaceutics 613, 121411, 2022
262022
Assessment of oral formulation-dependent characteristics of orodispersible tablets using texture profiles and multivariate data analysis
T Casian, C Bogdan, D Tarta, M Moldovan, I Tomuta, S Iurian
Journal of pharmaceutical and biomedical analysis 152, 47-56, 2018
262018
Biologically Active Ajuga Species Extracts Modulate Supportive Processes for Cancer Cell Development
VF Rauca, L Vlase, T Casian, A Sesarman, AM Gheldiu, A Mocan, ...
Frontiers in Pharmacology 10, 334, 2019
242019
Videometric mass flow control: A new method for real-time measurement and feedback control of powder micro-feeding based on image analysis
L Madarász, Á Köte, M Gyürkés, A Farkas, B Hambalkó, H Pataki, G Fülöp, ...
International Journal of Pharmaceutics 580, 119223, 2020
192020
Combination of PAT and mechanistic modeling tools in a fully continuous powder to granule line: Rapid and deep process understanding
A Domokos, É Pusztai, L Madarász, B Nagy, M Gyürkés, A Farkas, ...
Powder Technology 388, 70-81, 2021
172021
Data fusion strategies for performance improvement of a Process Analytical Technology platform consisting of four instruments: An electrospinning case study
T Casian, A Farkas, K Ilyés, B Démuth, E Borbás, L Madarász, Z Rapi, ...
International Journal of Pharmaceutics 567, 118473, 2019
172019
Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5‐fluorouracil in vivo
L Luput, A Sesarman, A Porfire, M Achim, D Muntean, T Casian, L Patras, ...
Cancer science 111 (4), 1344-1356, 2020
152020
Simultaneous quantification of atorvastatin and amlodipine in powder blends for tableting by NIR spectroscopy and chemometry
AL Vonica-Gligor, T Casian, A Reznek, I Tomuta, F Gligor
Farmacia 63 (3), 381-387, 2015
152015
Near Infra-Red spectroscopy for content uniformity of powder blends–Focus on calibration set development, orthogonality transfer and robustness testing
T Casian, S Iurian, A Gavan, C Revnic, S Porav, A Porfire, L Vlase, ...
Talanta 188, 404-416, 2018
142018
Definition and validation of the Design Space for co-milled nasal powder containing nanosized lamotrigine
P Gieszinger, I Tomuta, T Casian, C Bartos, P Szabó-Révész, R Ambrus
Drug Development and Industrial Pharmacy 44 (10), 1622-1630, 2018
132018
In-depth understanding of granule compression behavior under variable raw material and processing conditions
T Casian, S Iurian, A Gâvan, A Porfire, AL Pop, S Crișan, AM Pușcaș, ...
Pharmaceutics 14 (1), 177, 2022
102022
APPLYING THE PRINCIPLES OF QUALITY BY DESIGN (QbD) COUPLED WITH MULTIVARIATE DATA ANALYSIS (MVDA) IN ESTABLISHING THE IMPACT OF RAW MATERIAL VARIABILITY FOR EXTENDED RELEASE …
K Ilyes, T Casian, D Hales, G Borodi, L Rus, R ȘTIUFIUC, I TOMUȚĂ
Farmacia 69 (3), 2021
92021
Multivariate feed forward process control and optimization of an industrial, granulation based tablet manufacturing line using historical data
R Mathe, T Casian, I Tomuţă
International Journal of Pharmaceutics 591, 119988, 2020
92020
The system can't perform the operation now. Try again later.
Articles 1–20